The median (IQR) prostate-specific antigen at diagnosis was 6 ng/ml (5-10 ng/ml), 13.9% (28/202) reported T3 disease, and 5.9% (12/202) reported T4 disease; 39.6% (80/202) had intermediate grade (Gleason sum 7) and 22.8% (46/202) had high grade (Gleason sum 8-10) cancer. The gene discussed is KLK3; the disease is cancer.